Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


753 publications

2014 | 2013 | 2012 | 2011 | 2010 | ...
 
Medication use in pregnancy: a cross-sectional, multinational web-based study.
Lupattelli A., Spigset O., Twigg M.J., Zagorodnikova K., Mårdby A.C., Moretti M.E., Drozd M., Panchaud A., Hämeen-Anttila K., Rieutord A. et al., 2014/02. Bmj Open, 4 (2) pp. e004365.
 
Pharmacologie orthopédique
Livio F., Renard D., Senn L., Buclin T., 2014. pp. 35-70 dans Jolles-Haeberli B. (eds.) Manuel Pratique de Chirurgie Orthopédique chap. 2, Elsevier Masson.
 
Population pharmacokinetic approach to evaluate the effect of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on donepezil clearance.
Noetzli M., Guidi M., Ebbing K., Eyer S., Wilhelm L., Michon A., Thomazic V., Stancu I., Alnawaqil A.M., Bula C. et al., 2014. British Journal of Clinical Pharmacology, 78 (1) pp. 135-144. Peer-reviewed.
 
Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study.
Weber-Schoendorfer C., Chambers C., Wacker E., Beghin D., Bernard N., Network of French Pharmacovigilance Centers, Shechtman S., Shechtman S., Johnson D., Cuppers-Maarschalkerweerd B. et al., 2014. Arthritis and Rheumatology, 66 (5) pp. 1101-1110.
 
Risk perception by healthcare professionals related to drug use during pregnancy: a Swiss survey.
Csajka C., Jaquet A., Winterfeld U., Meyer Y., Einarson A., Panchaud A., 2014. Swiss Medical Weekly, 144 pp. w13936.
 
THCCOOH concentrations in whole blood: Are they useful in discriminating occasional from heavy smokers?
Fabritius M., Favrat B., Chtioui H., Battistella G., Annoni J.M., Appenzeller M., Dao K., Fornari E., Lauer E., Mall J.F. et al., 2014. Drug Testing and Analysis, 6 (1-2) pp. 155-163.
Tobramycin exposure from active calcium sulfate bone graft substitute.
Livio F., Wahl P., Csajka C., Gautier E., Buclin T., 2014. Bmc Pharmacology and Toxicology, 15 (1) p. 12. Peer-reviewed.
 
Towards a new combination therapy for tuberculosis with next generation benzothiazinones.
Makarov V., Lechartier B., Zhang M., Neres J., van der Sar A.M., Raadsen S.A., Hartkoorn R.C., Ryabova O.B., Vocat A., Decosterd L.A. et al., 2014. Embo Molecular Medicine, 6 (3) pp. 372-383. Peer-reviewed.
Intravenous streptomycin dosing regimen in a patient undergoing hemodialysis: Plasma level monitoring and pharmacokinetic simulation
Chtioui H., Zbinden D., Manuel O., Entenza J., Decosterd L.A., Buclin T., 2013/08. pp. e106 dans 11th Conference of the European Association for Clinical Pharmacology and Therapeutics, Clinical Therapeutics.
 
A control flow prototype for a dose recommending device for chronic myeloid leukemia patients
Simalatsar A., Wenqi Y., Dechao S., Gotta V., Widmer N., De Micheli G., 2013. dans 4th Workshop on Medical Cyber Physical Systems. Peer-reviewed.
 
A pain in the neck.
Puder J., Stadelmann R., Schoettker P., Buclin T., Grouzmann E., 2013. Clinical Chemistry, 59 (8) pp. 1280-1281.
 
A validated assay by liquid chromatography-tandem mass spectrometry for the simultaneous quantification of elvitegravir and rilpivirine in HIV positive patients.
Aouri M., Calmy A., Hirschel B., Telenti A., Buclin T., Cavassini M., Rauch A., Decosterd L.A., 2013. Journal of Mass Spectrometry, 48 (5) pp. 616-625.
 
A-Kinase Anchoring Protein Lbc Coordinates a p38 Activating Signaling Complex Controlling Compensatory Cardiac Hypertrophy.
Pérez López I., Cariolato L., Maric D., Gillet L., Abriel H., Diviani D., 2013. Molecular and Cellular Biology, 33 (15) pp. 2903-2917. Peer-reviewed.
 
Analysis and quantification of vitamin D metabolites in serum by ultra-performance liquid chromatography coupled to tandem mass spectrometry and high-resolution mass spectrometry: a method comparison and validation.
Bruce S.J., Rochat B., Béguin A., Pesse B., Guessous I., Boulat O., Henry H., 2013. Rapid Communications in Mass Spectrometry, 27 (1) pp. 200-206. Peer-reviewed.
 
Authors' response to: Statins in pregnancy: safety and perspectives of therapeutic applications.
Winterfeld U., Allignol A., Panchaud A., Rothuizen L., Merlob P., Cuppers-Maarschalkerweerd B., Vial T., Stephens S., Clementi M., De Santis M. et al., 2013. BJOG, 120 (11) p. 1440.
 
Benchmarking therapeutic drug monitoring software: A review of available computer tools
Fuchs A., Csajka C., Thoma Y., Buclin T., Widmer N., 2013. Clinical Pharmacokinetics, 52 (1) pp. 9-22. Peer-reviewed.
 
Biases on the administered parenteral doses of an experimental drug during phase I clinical trials
Perrottet Ries N., Brunner-Ferber F., Grouzmann E., Spertini F., Biollaz J., Buclin T., Widmer N., 2013. pp. e2-e3 dans 11th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), Clinical Therapeutics. Peer-reviewed.
 
Certificat de formation continue en Pharmacie clinique: une nouvelle opportunité de formation.
Panchaud A., Csajka C., 2013. PharmaJournal, 12 (6) pp. 17-18.
 
Clinical pharmacokinetics of imatinib and its therapeutic relevance
Widmer N., Gotta V., Haouala A., Blanc J., von Mehren M., Duchosal M., Leyvraz S., Csajka C., Decosterd L.A., Buclin T., 2013. pp. 15-43 dans Akhtari M., Elhemaidi I. (eds.) Imatinib: Chemical structure, pharmacology and adverse effects chap. 2, Nova Science Publishers.
 
Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: Results from the randomized controlled I-COME Trial
Gotta V., Widmer N., Decosterd L.A., Chalandon Y., Heim D., Benz R., Gregor M., Leoncini-Franscini L., Baerlocher G., Duchosal M. et al., 2013. pp. e6 dans 11th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), Clinical Therapeutics. Peer-reviewed.
 
Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint.
Fabritius M., Chtioui H., Battistella G., Annoni J.M., Dao K., Favrat B., Fornari E., Lauer E., Maeder P., Giroud C., 2013. Analytical and Bioanalytical Chemistry, 405 (30) pp. 9791-9803.
 
Contribution of CYP2B6 alleles in explaining extreme (S)-methadone plasma levels: a CYP2B6 gene resequencing study.
Dobrinas M., Crettol S., Oneda B., Lahyani R., Rotger M., Choong E., Lubomirov R., Csajka C., Eap C.B., 2013. Pharmacogenetics and Genomics, 23 (2) pp. 84-93. Peer-reviewed.
 
Determination of catecholamines in plasma and urine.
Grouzmann E., Lamine F., 2013. Best Practice and Research. Clinical Endocrinology and Metabolism, 27 (5) pp. 713-723.
 
Douleur chez la personne âgée. Ce qu'il faut faire différemment - ou pas
Renard D., 2013. Gazette Médicale - Info@gériatrie pp. 10-11.
Downregulation of cannabinoid receptor 1 from neuropeptide Y interneurons in the basal ganglia of patients with Huntington's disease and mouse models.
Horne E.A., Coy J., Swinney K., Fung S., Cherry A.E., Marrs W.R., Naydenov A.V., Lin Y.H., Sun X., Dirk Keene C. et al., 2013. European Journal of Neuroscience, 37 (3) pp. 429-440. Peer-reviewed.
Dysregulation of voltage-gated sodium channels by ubiquitin ligase NEDD4-2 in neuropathic pain.
Laedermann C.J., Cachemaille M., Kirschmann G., Pertin M., Gosselin R.D., Chang I., Albesa M., Towne C., Schneider B.L., Kellenberger S. et al., 2013. Journal of Clinical Investigation, 123 (7) pp. 3002-3013. Peer-reviewed.
 
Efavirenz intoxication due to a new CYP2B6 constellation.
Anagnostopoulos A., Rotger M., Aouri M., Kuster S.P., Telenti A., Décosterd L.A., Günthard H.F., 2013. Antiviral Therapy, 18 (5) pp. 739-743.
 
Effect of single nucleotide polymorphisms in cytochrome P450 isoenzyme and N-acetyltransferase 2 genes on the metabolism of artemisinin-based combination therapies in malaria patients from Cambodia and Tanzania.
Staehli Hodel E.M., Csajka C., Ariey F., Guidi M., Kabanywanyi A.M., Duong S., Decosterd L.A., Olliaro P., Beck H.P., Genton B., 2013. Antimicrobial Agents and Chemotherapy, 57 (2) pp. 950-958.
 
Etude multicentrique: antidépresseurs, grossesse et allaitement.
Weisskopf E., Lepigeon K., Fischer C., Morisod M., Bickle M., Eap C.B., Tolsa J.F., Vial Y., Csajka C., Panchaud A., 2013. Forum Gynécologie Suisse, 13 (2) pp. 4-6.
 
EzeCHiel validation: Comparison of gentamicin drug concentration predictions to a reference method (NONMEM)
Fuchs A., Thoma Y., Csajka C., Buclin T., Widmer N., 2013. dans Nano-Tera Annual Plenary Meeting.
 
Free and total plasma levels of lopinavir during pregnancy, at delivery and postpartum: implications for dosage adjustments in pregnant women.
Fayet-Mello A., Buclin T., Guignard N., Cruchon S., Cavassini M., Grawe C., Gremlich E., Popp K.A., Schmid F., Eap C.B. et al., 2013. Antiviral Therapy, 18 (2) pp. 171-182. Peer-reviewed.
 
Guide pratique des effets indésirables médicamenteux chez les seniors [Drug-induced adverse events in the elderly: a traveler's guide].
Barez T., Monod S., Livio F., Renard D., 2013. Revue Médicale Suisse, 9 (405) pp. 2054-2058.
Hemodialysis for cefepime intoxication: A case report
Mani L.Y., Kissling S., Burnier M., Buclin T., Renard D., 2013. pp. e24 dans 11th Conference of the European Association for Clinical Pharmacology and Therapeutics, Clinical Therapeutics.
 
High-throughput and sensitive quantitation of plasma catecholamines by ultraperformance liquid chromatography-tandem mass spectrometry using a solid phase microwell extraction plate.
Dunand M., Gubian D., Stauffer M., Abid K., Grouzmann E., 2013. Analytical Chemistry, 85 (7) pp. 3539-3544.
 
Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid.
Cusini A., Vernazza P.L., Yerly S., Decosterd L.A., Ledergerber B., Fux C.A., Rohrbach J., Widmer N., Hirschel B., Gaudenz R. et al., 2013. Journal of Acquired Immune Deficiency Syndromes, 62 (1) pp. 28-35. Peer-reviewed.
 
Imatinib-induced dose-dependent interstitial lung disease successfully switched to nilotinib: a case report with concentration exposure data.
Dao K., Védy D., Lopez J., Staneczek O., Buclin T., Livio F., 2013. International Journal of Hematology, 97 (2) pp. 299-300.
 
Intraocular penetration of penciclovir after oral administration of famciclovir: a population pharmacokinetic model.
Schenkel F., Csajka C., Baglivo E., Kondo-Oestreicher M., Dayer P., Gex-Fabry M., Daali Y., 2013. Journal of Antimicrobial Chemotherapy, 68 (7) pp. 1635-1641. Peer-reviewed.
 
Lack of Enantioselectivity in the SULT1A3-catalyzed Sulfoconjugation of Normetanephrine Enantiomers: An In Vitro and Computational Study.
Grouzmann E., Gualtierotti J.B., Gerber-Lemaire S., Abid K., Brakch N., Pedretti A., Testa B., Vistoli G., 2013. Chirality, 25 pp. 28-34. Peer-reviewed.
 
Long-term prospective population PK study in GIST patients--letter.
Chatelut E., Gandia P., Gotta V., Widmer N., 2013. Clinical Cancer Research, 19 (4) p. 949. Peer-reviewed.
 
Medikamente, Schwangerschaft und Stillzeit: nicht alle Informationsquellen sind verlässlich
Panchaud A., Berger J., Csajka C., Bugnon O., 2013. PharmaJournal, 151 (1) pp. 16-17.
 
Metabotype analysis for personalized biology: a new bioanalytical territory for high-resolution MS.
Bertrand R., Amélie F., Pierre-Edouard S., 2013. Bioanalysis, 5 (10) pp. 1149-1152.
 
Milbemycins: more than efflux inhibitors for fungal pathogens.
Silva L.V., Sanguinetti M., Vandeputte P., Torelli R., Rochat B., Sanglard D., 2013/01. Antimicrobial Agents and Chemotherapy, 57 (2) pp. 873-886. Peer-reviewed.
 
Multiplex liquid chromatography-tandem mass spectrometry assay for simultaneous therapeutic drug monitoring of ribavirin, boceprevir, and telaprevir.
Aouri M., Moradpour D., Cavassini M., Mercier T., Buclin T., Csajka C., Telenti A., Rauch A., Decosterd L.A., 2013. Antimicrobial Agents and Chemotherapy, 57 (7) pp. 3147-3158. Peer-reviewed.
 
Médicaments tocolytiques: utilisation en cas de menace d'accouchement prématuré.
Weisskopf E., Lepigeon K., Baud D., Csajka C., Panchaud A., 2013. PharmaJournal, 19 (9) pp. 5-7.
 
Médicaments, grossesse et allaitement: toutes les sources d'information ne sont pas fiables!
Panchaud A., Berger J., Csajka C., Bugnon O., 2013. PharmaJournal, 151 (1) pp. 15-16.
 
Personalized drug administrations using Support Vector Machine
You W., Simalatsar A., Widmer N., De Micheli G., 2013. BioNanoScience, 3 (4) pp. 378-393. Peer-reviewed.
 
Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals.
Lubomirov R., Arab-Alameddine M., Rotger M., Fayet-Mello A., Martinez R., Guidi M., di Iulio J., Cavassini M., Günthard H.F., Furrer H. et al., 2013. Pharmacogenetics and Genomics, 23 (1) pp. 9-18. Peer-reviewed.
 
Pharmacokinetic interaction between methotrexate and chloral hydrate.
Dao K., Ivanyuk A., Buclin T., Beck-Popovic M., Diezi M., 2013. Pediatric Blood and Cancer, 60 (3) pp. 518-520.
 
Pharmacovigilance [Pharmacovigilance update].
Livio F., 2013. Revue Médicale Suisse, 9 (368) pp. 72-75.
Population pharmacokinetic study of gentamicin: A retrospective analysis in a large cohort of neonate patients
Fuchs A., Guidi M., Giannoni E., Buclin T., Widmer N., Csajka C., 2013. pp. Abstract 2906 dans 22nd Population Approach Group in Europe (PAGE) Meeting, PAGE. Abstracts of the Annual Meeting of the Population Approach Group in Europe. Peer-reviewed.
 
Population pharmacokinetic study of memantine: effects of clinical and genetic factors.
Noetzli M., Guidi M., Ebbing K., Eyer S., Wilhelm L., Michon A., Thomazic V., Alnawaqil A.M., Maurer S., Zumbach S. et al., 2013. Clinical Pharmacokinetics, 52 (3) pp. 211-223. Peer-reviewed.
Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients.
Staehli Hodel E.M., Guidi M., Zanolari B., Mercier T., Duong S., Kabanywanyi A.M., Ariey F., Buclin T., Beck H.P., Decosterd L.A. et al., 2013. Malaria Journal, 12 p. 235. Peer-reviewed.
 
Prediction of drug concentration using parametrized Support Vector Machines
You W., Simalatsar A., Widmer N., De Micheli G., 2013. dans Nano-Tera Annual Plenary Meeting.
 
Prediction of free imatinib concentrations based on total plasma concentrations in patients with gastrointestinal stromal tumours.
Haouala A., Widmer N., Guidi M., Montemurro M., Leyvraz S., Buclin T., Eap C.B., Decosterd L.A., Csajka C., 2013. British Journal of Clinical Pharmacology, 75 (4) pp. 1007-1018. Peer-reviewed.
Pregnancy outcome following maternal exposure to Mirtazapine: Preliminary results of a collaborative ENTIS study.
Winterfeld U., Buclin T., Klinger G., Panchaud A., Stephens S., Arnon J., Malm H., te Winkel B., Clementi M., Pistelli A. et al., 2013. pp. e1-e2 dans 11th Conference of the European Association for Clinical Pharmacology and Therapeutics, Clinical Therapeutics.
 
Pregnancy outcome following maternal exposure to statins: a multicentre prospective study.
Winterfeld U., Allignol A., Panchaud A., Rothuizen L.E., Merlob P., Cuppers-Maarschalkerweerd B., Vial T., Stephens S., Clementi M., De Santis M. et al., 2013. BJOG, 120 (4) pp. 463-471. Peer-reviewed.
 
Prescription du monitoring pratique médicate: de l'empirisme eclairé aux stratégies rationnelles [Prescribing monitoring in clinical practice: from enlightened empiricism to rational strategies].
Buclin T., Herzig L., 2013. Revue Médicale Suisse, 9 (386) pp. 1037-1041.
 
Relationship of CYP2D6, CYP3A, POR, and ABCB1 Genotypes With Galantamine Plasma Concentrations.
Noetzli M., Guidi M., Ebbing K., Eyer S., Zumbach S., Giannakopoulos P., von Gunten A., Csajka C., Eap C.B., 2013. Therapeutic Drug Monitoring, 35 (2) pp. 270-275. Peer-reviewed.
 
Response to Calcagno comment on"Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid"
Cusini A., Ledergerber B., Widmer N., Günthard H.F., 2013. Journal of Acquired Immune Deficiency Syndromes, 64 (2) pp. e14-e15. Peer-reviewed.
 
Response to Diaz and de Leon "The Mathematics of Drug Dose Individualization Should be Built With Random Effects Linear Models".
Holford N.H., Buclin T., 2013. Therapeutic Drug Monitoring, 35 (6) pp. 873-874.
Simulation-based systematic review of imatinib population pharmacokinetics and PK-PD relationships in chronic myeloid leukemia (CML) patients
Gotta V., Buclin T., Widmer N., Csajka C., 2013. pp. Abstract 2904 dans 22nd Population Approach Group in Europe (PAGE) Meeting, PAGE. Abstracts of the Annual Meeting of the Population Approach Group in Europe. Peer-reviewed.
 
Spectrum of ocular digoxin toxicity in the elderly: A case report
Renard D., Rubli E., Voide N., Borruat F.X., Rothuizen L., 2013. pp. e22-e23 dans 11th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), Clinical Therapeutics.
Strategies for the development of tdm for targeted anticancer agents
Buclin T., 2013. pp. e113-e114 dans 11th Conference of the European Association for Clinical Pharmacology and Therapeutics, Clinical Therapeutics.
Suivi thérapeutique des concentrations d'inhibiteurs de tyrosine kinase et d'autres médicaments oncologiques = Therapeutisches Drug-Monitoring der Konzentration von Tyrosinkinase-Inhibitoren und anderen Onkologika
Widmer N., 2013. Pipette Swiss Laboratory Medicine 3 pp. 8-9.
 
Systematic review of population pharmacokinetic analyses of imatinib and relationships with treatment outcomes
Gotta V., Buclin T., Csajka C., Widmer N., 2013. Therapeutic Drug Monitoring, 35 (2) pp. 150-167. Peer-reviewed.
 
The anticancer drug tamoxifen counteracts the pathology in a mouse model of duchenne muscular dystrophy.
Dorchies O.M., Reutenauer-Patte J., Dahmane E., Ismail H.M., Petermann O., Patthey- Vuadens O., Comyn S.A., Gayi E., Piacenza T., Handa R.J. et al., 2013. American Journal of Pathology, 182 (2) pp. 485-504.
The epithelial sodium channel mediates the directionality of galvanotaxis in human keratinocytes.
Yang H.Y., Charles R.P., Hummler E., Baines D.L., Isseroff R.R., 2013. Journal of Cell Science, 126 (Pt 9) pp. 1942-1951.
Toxic and drug-induced peripheral neuropathies: updates on causes, mechanisms and management.
Diezi M., Buclin T., Kuntzer T., 2013. Current Opinion in Neurology, 26 (5) pp. 481-488. Peer-reviewed.
 
Ultra-high pressure liquid chromatography-mass spectrometry for plant metabolomics: a systematic comparison of high-resolution quadrupole-time-of-flight and single stage Orbitrap mass spectrometers.
Glauser G., Veyrat N., Rochat B., Wolfender J.L., Turlings T.C., 2013. Journal of Chromatography. A, 1292 pp. 151-159.
Une attente encore trop longue. Du développement à l'utilisation la plus juste des nouveaux traitements.
Buclin T., 2013. Courrier du Médecin Vaudois 6 p. 7.
 
Use of High Doses of Quetiapine in Bipolar Disorder Episodes are not Linked to High Activity of Cytochrome P4503A4 and/or Cytochrome P4502D6.
Khazaal Y., Preisig M., Chatton A., Kaufmann N., Bilancioni R., Eap C.B., 2013. Psychiatric Quarterly, 84 (3) pp. 329-335. Peer-reviewed.
 
α₁-Adrenergic receptors contribute to the acute effects of 3,4-methylenedioxymethamphetamine in humans.
Hysek C.M., Fink A.E., Simmler L.D., Donzelli M., Grouzmann E., Liechti M.E., 2013. Journal of Clinical Psychopharmacology, 33 (5) pp. 658-666. Peer-reviewed.
 
La Pharmacie en mutation = Die Apotheke im Wandel
Ledermann F., Geissbühler A., Borchard G., Mühlebach S., Locca J.F., Bezençon J., Widmer N., 2012/03. Pharmajournal, 150 (6) pp. 21-22.
 
Effects of the α₂-adrenergic agonist clonidine on the pharmacodynamics and pharmacokinetics of 3,4-methylenedioxymethamphetamine in healthy volunteers.
Hysek C.M., Brugger R., Simmler L.D., Bruggisser M., Donzelli M., Grouzmann E., Hoener M.C., Liechti M.E., 2012/02. Journal of Pharmacology and Experimental Therapeutics, 340 (2) pp. 286-294.
 
A drug administration decision support system
You W., Simalatsar A., Widmer N., De Micheli G., 2012. pp. 122-129 dans 2012 Workshop on Pharmaco-Informatics for Drug Discovery in Conjunction with 2012 IEEE International Conference on Bioinformatics and Biomedicine (BIBM 2012). Peer-reviewed.
 
A highly sensitive LC-tandem MS assay for the measurement in plasma and in urine of salbutamol administered by nebulization during mechanical ventilation in healthy volunteers.
Sidler-Moix A.L., Mercier T., Decosterd L.A., Di Paolo E.R., Berger-Gryllaki M., Cotting J., Pannatier A., 2012. Biomedical Chromatography : BMC, 26 (5) pp. 672-680. Peer-reviewed.
 
A survey on the enlistment of pharmacists in a hospital battalion of the Swiss Armed Forces
Krähenbühl J.M., Kurmann P., Hürlimann P., Cecconi M., Guillod Y., Friggeri C., Freudweiler M., Widmer N., 2012. dans World Congress of Pharmacy and Pharmaceutical Sciences 2012 FIP Centennial Congress.
 
Agents anti-infectieux et fonction réna!e: vers des posologies sur mesure [Antimicrobial agents and renal elimination: towards individual dosage adjustment?].
Willi-Robatel C., Senn L., Livio F., Zanetti G., Marchetti O., Buclin T., 2012. Revue Médicale Suisse, 8 (338) pp. 894-900.
 
Antimicrobial Agents
Csajka C., Marchetti O., Manuel O., Decosterd L., Telenti A., 2012. pp. 379-402 dans Anzenbacher P., Zanger U.M. (eds.) Metabolism of Drugs and Other Xenobiotics chap. 14, Wiley-VCH Verlag.
 
Bedeutet eine radiologische Untersuchung immer eine Gefahr für das ungeborene Kind?
Panchaud A., Verdun F.R., Csajka C., 2012. PharmaJournal, 150 (17) pp. 8-11.
 
Benchmarking therapeutic drug monitoring software: A systematic evaluation of available computer tools
Fuchs A., Csajka C., Thoma Y., Buclin T., Widmer N., 2012. pp. 113S-114S dans 80. Jahresversammlung der Schweizerischen Gesellschaft für Allgemeine Innere Medizin, Swiss Medical Forum. Peer-reviewed.
Benchmarking therapeutic drug monitoring software: A systematic evaluation of available computer tools
Fuchs A., Csajka C., Thoma Y., Buclin T., Widmer N., 2012. p. 2351 dans 21st Population Approach Group in Europe (PAGE) Meeting, Abstracts of the Annual Meeting of the Population Approach Group in Europe. Peer-reviewed.
 
Benchmarking therapeutic drug monitoring software: A systematic evaluation of available computer tools
Fuchs A., Csajka C., Thoma Y., Buclin T., Widmer N., 2012. dans Nano-Tera Annual Plenary Meeting.
 
Carence en fer sans anémie chez l'enfant et l'adolescent: un traitement intraveineux est-il indiqué? Justifié?
Cachat F, Diezi M, Beck-Popovic M, 2012. Paediatrica, 23 (2) pp. 32-41.
 
Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans.
Hysek C., Schmid Y., Rickli A., Simmler L.D., Donzelli M., Grouzmann E., Liechti M.E., 2012. British Journal of Pharmacology, 166 (8) pp. 2277-2288. Peer-reviewed.
 
Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections.
Pascual A., Csajka C., Buclin T., Bolay S., Bille J., Calandra T., Marchetti O., 2012. Clinical Infectious Diseases, 55 (3) pp. 381-390.
 
Cytogenetic response to imatinib in chronic myeloid leukaemia patients: concentration dependency and associated influences under field-conditions
Gotta V., Bouchet S., Widmer N., Csajka C., Buclin T., Mahon F.-X., Molimard M., 2012. pp. 107S dans 80. Jahresversammlung der Schweizerischen Gesellschaft für Allgemeine Innere Medizin, Swiss Medical Forum. Peer-reviewed.
Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapy.
Glass T.R., Rotger M., Telenti A., Decosterd L., Csajka C., Bucher H.C., Günthard H.F., Rickenbach M., Nicca D., Hirschel B. et al., 2012/01. Plos One, 7 (1) pp. e29186. Peer-reviewed.
 
Dosage optimization of treatments using population pharmacokinetic modeling and simulation.
Guidi M., Arab-Alameddine M., Rotger M., Aouri M., Telenti A., Decosterd L.A., Buclin T., Csajka C., Swiss HIV Cohort Study, 2012. Chimia, 66 (5) pp. 291-295. Peer-reviewed.
 
Drug interactions between voriconazole, darunavir/ritonavir and etravirine in an HIV-infected patient with Aspergillus pneumonia.
Aouri M., Decosterd L.A., Buclin T., Hirschel B., Calmy A., Livio F., 2012. AIDS, 26 (6) pp. 776-778.
Duloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory study.
Hysek C.M., Simmler L.D., Nicola V.G., Vischer N., Donzelli M., Krähenbühl S., Grouzmann E., Huwyler J., Hoener M.C., Liechti M.E., 2012. Plos One, 7 (5) pp. e36476.
 
Effect of population-based screening on breast cancer mortality.
Riva C., Biollaz J., Foucras P., Junod B., Nicot P., Spinosa J.P., 2012. Lancet, 379 (9823) pp. 1296; author reply 1298.
 
Etude d'inhalation contrôlée chez les fumeurs occasionnels et réguliers de cannabis: comparaison des profils cinétiques des cannabinoïdes et effets comportementaux (O11)
Giroud C., Fabritius M., Battistella G., Fornari E., Lauer E., Dao K., Mall J.-F., Appenzeller M., Annoni J.M., Favrat B. et al., 2012., Société Française de Toxicologie Analytique pp. S1-5/S1-6 dans 20e congrès de la Société Française de Toxicologie Analytique (SFTA) 19-21 septembre 2012, Chambéry, France, Annales de Toxicologie Analytique / Annals of Analytical Toxicology.
 
EzeCHiel: Drug concentration prediction and analysis software
Noverraz B., Stadelmann J., Sambuc L., Gotta V., Fuchs A., Widmer N., Buclin T., Thoma Y., 2012. dans Nano-Tera Annual Plenary Meeting.
 
Impact of tamoxifen dose on tamoxifen and its active metabolites exposure in breast cancer patients: preliminary results from a prospective, open-label trial
Dahmane E., Zaman K., Galmiche Rindisbacher M., Berthod G., Perey L., Bodmer A., Leyvraz S., Eap C., Decosterd L., Buclin T. et al., 2012. pp. 108S dans 80. Jahrestagung der Schweizerischen Gesellschaft für Allgemeine Innere Medizin, Swiss Medical Forum = Forum Médical Suisse.
 
Inhibiteurs des tyrosines kinases dans la LMC: Guide pratique des interactions médicamenteuses
Widmer N., Decosterd L.A., Nicolini F., Rothuizen L., Réa D., 2012., 2012 80, Editions Scientifiques L & C.
Late onset tacrolimus-induced life-threatening polyneuropathy in a kidney transplant recipient patient
Renard D., Gauthier T., Venetz J.-P., Buclin T., Kuntzer T., 2012. Clinical Kidney Journal, 5 (4) pp. 323-326. Peer-reviewed.
 
Management of deficient lactation in Switzerland and Canada: a survey of midwives' current practices.
Winterfeld U., Meyer Y., Panchaud A., Einarson A., 2012. Breastfeeding Medicine, 7 pp. 317-318.
 
Monitoring drug therapy.
Buclin T., Gotta V., Fuchs A., Widmer N., Aronson J., 2012. British Journal of Clinical Pharmacology, 73 (6) pp. 917-923. Peer-reviewed.
 
Médicaments, grossesse et allaitement
Panchaud A., Berger J., Bugnon O., 2012. BabyGuide, 2012 pp. 31-33.
 
Pharmacokinetic (PK)-based dosage individualization of imatinib: evaluation of efficiency and clinical usefulness
Gotta V., Widmer N., Decosterd L.A., Montemurro M., Leyvraz S., Chalandon Y., Heim D., Gregor M., Benz R., Leoncini-Franscini L. et al., 2012. dans 3rd Symposium of the Swiss Clinical Trial Organisation (SCTO), Personalised Medicine in Clinical Research.
 
Pharmacokinetic and pharmacodynamic analysis of efavirenz dose reduction using an in vitro-in vivo extrapolation model.
Siccardi M., Almond L., Schipani A., Csajka C., Marzolini C., Wyen C., Brockmeyer N.H., Boffito M., Owen A., Back D., 2012. Clinical Pharmacology and Therapeutics, 92 (4) pp. 494-502.
 
Pharmacovigilance [Pharmacovigilance].
Livio F., Renard D., Buclin T., 2012. Revue Médicale Suisse, 8 (324) pp. 116-119.
 
Pharmacovigilance in pregnancy: adverse drug reactions associated with fetal disorders.
Wettach C., Thomann J., Lambrigger-Steiner C., Buclin T., Desmeules J., von Mandach U., 2012. Journal of Perinatal Medicine, 41 (3) pp. 301-307. Peer-reviewed.
 
Photodynamic induced uptake of liposomal doxorubicin to rat lung tumors parallels tumor vascular density.
Wang Y., Gonzalez M., Cheng C., Haouala A., Krueger T., Peters S., Decosterd L.A., van den Bergh H., Perentes J.Y., Ris H.B. et al., 2012. Lasers in Surgery and Medicine, 44 (4) pp. 318-324. Peer-reviewed.
 
Population pharmacokinetic analysis and pharmacogenetics of raltegravir in HIV-positive and healthy individuals.
Arab-Alameddine M., Fayet-Mello A., Lubomirov R., Neely M., di Iulio J., Owen A., Boffito M., Cavassini M., Günthard H.F., Rentsch K. et al., 2012. Antimicrobial Agents and Chemotherapy, 56 (6) pp. 2959-2966.
 
Population pharmacokinetics in chronic myeloid leukaemia patients: observations under field-conditions
Gotta V., Bouchet S., Widmer N., Mahon F.-X., Molimard M., Buclin T., Csajka C., 2012. pp. 111S-112S dans 80. Jahresversammlung der Schweizerischen Gesellschaft für Allgemeine Innere Medizin, Swiss Medical Forum. Peer-reviewed.
Pragmatic approach for interpreting antiretroviral drug concentrations based on a systematic review of population pharmacokinetic studies
Arab-Alameddine M., Buclin T., Guidi M., Widmer N., Decosterd L.A., Csajka C., 2012. pp. Abstr 2441 dans 21st Population Approach Group in Europe (PAGE) meeting, Abstracts of the Annual Meeting of the Population Approach Group in Europe. Peer-reviewed.
 
Pregnancy outcome following exposure to topical retinoids: a multicenter prospective study.
Panchaud A., Csajka C., Merlob P., Schaefer C., Berlin M., De Santis M., Vial T., Ieri A., Malm H., Eleftheriou G. et al., 2012. Journal of Clinical Pharmacology, 52 (12) pp. 1844-1851. Peer-reviewed.
 
Pregnancy outcomes following use of escitalopram: a prospective comparative cohort study.
Klieger-Grossmann C., Weitzner B., Panchaud A., Pistelli A., Einarson T., Koren G., Einarson A., 2012. Journal of Clinical Pharmacology, 52 (5) pp. 766-770. Peer-reviewed.
 
Preliminary results of venlafaxine exposure in pregnancy, a multicenter prospective cohort ENTIS study
Te Winkel B.A., Beghin D., Pistelli A., Carusod A., Cassina M., Lorenzi F., Malm H.T., Panchaud A., Stahl B., 2012. pp. 171-172 dans 40th Annual Conference of the European Teratology Society, Reproductive Toxicology. Peer-reviewed.
 
Prevalence and determinants of QT interval prolongation in medical inpatients.
Pasquier M., Pantet O., Hugli O., Pruvot E., Buclin T., Waeber G., Aujesky D., 2012. Internal Medicine Journal, 42 (8) pp. 933-940.
 
Prevalence, incidence and indications of hypno-sedative treatments in hospitalized patients aged 75 and older
Von Rohr T.R., Rochat S., Monod S., Buela C., Buclin T., Renard D., Csajka C., 2012. p. 228 dans 40th International Symposium on Clinical Pharmacy (ESCP), Clinical Pharmacy: Connecting Care and Outcomes, International Journal of Clinical Pharmacy.
 
Principes d'evaluation et de prise en charge des patients agés polymorbides: guide a l'intention des cliniciens [Principles for the assessment and management of polymorbid elderly patients: a guide for clinicians].
Riat F., Rochat S., Büla C., Renard D., Monod S., 2012. Revue Médicale Suisse, 8 (361) pp. 2109-2114.
Probability of achieving optimal molecular response to imatinib in chronic myeloid leukemia (CML) patients: Pharmacokinetic/Pharmacodynamic (PK/PD) relationships observed under field-conditions
Gotta V., Bouchet S., Widmer N., Mahon F.X., Molimard M., Buclin T., Csajka C., 2012. p. 2504 dans 21st Population Approach Group in Europe (PAGE) Meeting, Abstracts of the Annual Meeting of the Population Approach Group in Europe. Peer-reviewed.
 
Quantitative/qualitative analysis using LC-HRMS: the fundamental step forward for clinical laboratories and clinical practice.
Rochat B., 2012. Bioanalysis, 4 (14) pp. 1709-1711.
 
Rates of major malformations in infants following exposure to duloxetine during pregnancy: a preliminary report.
Einarson A., Smart K., Vial T., Diav-Citrin O., Yates L., Stephens S., Pistelli A., Kennedy D., Taylor T., Panchaud A. et al., 2012. Journal of Clinical Psychiatry, 73 (11) p. 1471. Peer-reviewed.
 
Safe and effective variability-a criterion for dose individualization.
Holford N.H., Buclin T., 2012. Therapeutic Drug Monitoring, 34 (5) pp. 565-568. Peer-reviewed.
 
SVM-based Drug Administration Decision Support System
You W., Simalatsar A., Widmer N., De Micheli G., 2012. dans Nano-Tera Annual Plenary Meeting.
 
Syndrome sérotoninergique: mise au point et revue des cas annoncés en Suisse [Serotonin syndrome: review and case series from the Swiss pharmacovigilance system].
Chassot M., Munz T., Livio F., Buclin T., 2012. Revue Médicale Suisse, 8 (360) pp. 2086-2090.
 
Synthetic calibrators for the analysis of total metanephrines in urine: revisiting the conditions of hydrolysis.
Simonin J., Gerber-Lemaire S., Centeno C., Seghezzi C., Iglesias K., Abid K., Grouzmann E., 2012. Clinica Chimica Acta, 413 (11-12) pp. 998-1003. Peer-reviewed.
 
The future key role of LC-high-resolution-MS analyses in clinical laboratories: a focus on quantification.
Rochat B., Kottelat E., McMullen J., 2012. Bioanalysis, 4 (24) pp. 2939-2958.
The Swiss young pharmacists group: Preparing for the future by examining the past
Ledermann F., Geissbühler A., Borchard G., Mühlebach S., Locca J.F., Bezençon J., Widmer N., 2012. International Pharmacy Journal, 28 (1) pp. 20-23.
 
Therapeutic drug monitoring of imatinib: Bayesian and alternative methods to predict trough levels
Gotta V., Widmer N., Montemurro M., Leyvraz S., Haouala A., Decosterd L.A., Csajka C., Buclin T., 2012. Clinical Pharmacokinetics, 51 (3) pp. 187-201. Peer-reviewed.
 
Therapeutic drug monitoring of targeted anticancer therapy. Tyrosine kinase inhibitors and selective estrogen receptor modulators: A clinical pharmacology laboratory perspective
Decosterd L.A., Dahmane E., Neeman M., Buclin T., Csajka C., Haouala A., Widmer N., 2012. pp. 197-250 dans Xu Q.A, Madden T.L. (eds.) LC-MS in drug bioanalysis chap. 9, Springer.
 
Un examen radiologique est-il toujours à risque pour l'enfant à naître?
Panchaud A., Verdun F. R., Csajka C., 2012. PharmaJournal, 150 (17) pp. 5-8.
 
Vancomycin exposure from active calcium sulfate bone filler
Livio F., Guidi M., Wahl P., Gautier E., Prod'Hom G., Buclin T., Csajka T., 2012. pp. 112S dans 80. Jahrestagung der Schweizerischen Gesellschaft für Allgemeine Innere Medizin, Swiss Medical Forum = Forum Médical Suisse.
Traitement et prophylaxie de la Maladie ThromboEmbolique Veineuse (MTEV)
Centre hospitalier universitaire vaudois, Policlinique médicale universitaire (Lausanne) , 2011/05. 2 p..
 
Effets du cannabis sur les fumeurs occasionnels
Giroud C., Battistella G., Thomas A., Maeder P., Mall J.F., Annoni J.M., Appenzeller M., Buclin T., Staub C., Mangin P. et al., 2011/03., Société Française de Toxicologie Analytique (SFTA) pp. S1-8 dans Société Française de Toxicologie Analytique (SFTA) (eds.) Annales de toxicologie analytique, EDP Sciences.
 
A randomized cross-over study to compare raltegravir and efavirenz (SWITCH-ER study).
Nguyen A., Calmy A., Delhumeau C., Mercier I., Cavassini M., Mello A.F., Elzi L., Rauch A., Bernasconi E., Schmid P. et al., 2011. Aids, 25 (12) pp. 1481-1487.
 
Antiretroviral drug toxicity in relation to pharmacokinetics, metabolic profile and pharmacogenetics.
Arab-Alameddine M., Décosterd L.A., Buclin T., Telenti A., Csajka C., 2011. Expert Opinion On Drug Metabolism and Toxicology, 7 (5) pp. 609-622.
 
Cell disposition of raltegravir and newer antiretrovirals in HIV-infected patients: high inter-individual variability in raltegravir cellular penetration.
Fayet Mello A., Buclin T., Franc C., Colombo S., Cruchon S., Guignard N., Biollaz J., Telenti A., Decosterd L.A., Cavassini M., 2011. Journal of Antimicrobial Chemotherapy, 66 (7) pp. 1573-1581.
Correlations between imatinib pharmacokinetics, pharmacodynamics, adherence, and clinical response in advanced metastatic gastrointestinal stromal tumor (GIST): An emerging role for drug blood level testing?
von Mehren M., Widmer N., 2011. Cancer Treatment Reviews, 37 (4) pp. 291-299. Peer-reviewed.
Development and Validation of Decision Rules to Guide Frequency of Monitoring CD4 Cell Count in HIV-1 Infection before Starting Antiretroviral Therapy.
Buclin T., Telenti A., Perera R., Csajka C., Furrer H., Aronson J.K., Glasziou P.P., 2011. Plos One, 6 (4) pp. e18578.
 
Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib.
Haouala A., Widmer N., Duchosal M.A., Montemurro M., Buclin T., Decosterd L.A., 2011. Blood, 117 (8) pp. e75-e87. Peer-reviewed.
 
Engagements des pharmaciens militaires de milice dans les bataillons hôpital de l'armée [Einsätze der Miliz-Militärapotheker in den Spitalbataillonen der Armee]
Widmer N., Krähenbühl J.M., Kurmann P., Hürlimann P., Cecconi M., Guillod Y., Friggeri C., Freudweiler M., 2011. GSASA Journal, 25 (4) pp. 107-111.
 
Evaluation of risk perception related to drug use during pregnancy: a Swiss survey
Jaquet A., Winterfeld U., Meyer Y., Buclin T., Csajka C., Panchaud A., 2011. pp. 422-423 dans 39th ESCP European Symposium on Clinical Pharmacy and 13th SFPC Congress: Clinical Pharmacy at the Front Line of Innovations, International Journal of Clinical Pharmacy. Peer-reviewed.
 
Example-based support vector machine for drug concentration analysis
You W., Widmer N., De Micheli G., 2011. pp. 153-157 dans EMBC 2011, 33rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Proceedings of the 33rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC 2011). Peer-reviewed.
 
Example-Based Support Vector Machine for Personalized Medicine
You W., Widmer N., Simalatsar A., De Micheli G., 2011. dans Nano-Tera Annual Plenary Meeting.
 
FXYD Proteins Reverse Inhibition of the Na+-K+ Pump Mediated by Glutathionylation of Its {beta}1 Subunit.
Bibert S., Liu C.C., Figtree G.A., Garcia A., Hamilton E.J., Marassi F.M., Sweadner K.J., Cornelius F., Geering K., Rasmussen H.H., 2011. Journal of Biological Chemistry, 286 (21) pp. 18562-18572.
 
Generic approach for the sensitive absolute quantification of large undigested peptides in plasma using a particular liquid chromatography-mass spectrometry setup.
Sobhi H.R., Vatansever B., Wortmann A., Grouzmann E., Rochat B., 2011. Journal of Chromatography. A, 1218 (47) pp. 8536-8543.
 
How quickly should we titrate antihypertensive medication? Systematic review modelling blood pressure response from trial data.
Lasserson D.S., Buclin T., Glasziou P., 2011. Heart, 97 (21) pp. 1771-1775.
 
How to Improve the Use of Proton Pump Inhibitors
Hodel M., Pauchet A., Buclin T., Mottet C., Gloor S., Guyot C., Biolat J., Chtioui H., Genne D., 2011. p. 164 dans 10th Congress of the European Association for Clinical Pharmacology and Therapeutics, Basic & Clinical Pharmacology & Toxicology. Peer-reviewed.
 
Impact of videogame playing on glucose metabolism in children with type 1 diabetes.
Phan-Hug Franziska, Thurneysen Esther, Theintz Gérald, Ruffieux Christiane, Grouzmann Eric, 2011. Pediatric Diabetes, 12 (8) pp. 713-717. Peer-reviewed.
 
Improvement of therapeutic drug monitoring of imatinib by Bayesian prediction of trough levels. Personalized drug dosage
Gotta V., Widmer N., Montemurro M., Leyvraz S., Haouala A., Decosterd L.A., Csajka C., Buclin T., 2011. p. 478 dans 12th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT), Therapeutic Drug Monitoring. Peer-reviewed.
 
Letter to the editor response to the article of Luisa Lina Villa HPV prophylactic vaccination: the first years and what to expect from now, in press.
Spinosa J.P., Riva C., Biollaz J., 2011. Cancer Letters, 304 (1) p. 70.
 
Lipid and lipoprotein profile in HIV-infected patients treated with lopinavir/ritonavir as a component of the first combination antiretroviral therapy.
Magenta L., Dell-Kuster S., Richter W.O., Young J., Hasse B., Flepp M., Hirschel B., Vernazza P., Evison J., Cavassini M. et al., 2011. Aids Research and Human Retroviruses, 27 (5) pp. 525-533.
 
Nedd4-2-dependent ubiquitylation and regulation of the cardiac potassium channel hERG1.
Albesa M., Grilo L.S., Gavillet B., Abriel H., 2011. Journal of Molecular and Cellular Cardiology, 51 (1) pp. 90-98.
 
Need of reduced and harmonized bureaucracy in multi-centre clinical research - a case-report from a Swiss trial
Gotta V., Vallotton L., Widmer N., Buclin T., 2011. p. 7 dans 2011 Joint Annual Meeting of the German, Swiss, and Austrian Societies for Clinical Pharmacology and Toxicology, British Journal of Clinical Pharmacology. Peer-reviewed.
 
P-glycoprotein modulation by valspodar and cyclosporin does not increase tumor uptake of doxorubicin administered via isolated lung perfusion to rats bearing sarcoma lung metastases.
Kuemmerle A., Yan H., Krueger T., Buclin T., Braissant O., Henry H., Ris H.B., Decosterd L.A., 2011. Anticancer Research, 31 (6) pp. 2121-2128.
 
Personalized drug dosage: Monitoring of imatinib concentration with a Bayesian interpretation tool
Gotta V., Widmer N., Montemurro M., Leyvraz S., Haouala A., Decosterd L.A., Csajka C., Buclin T., 2011. dans Nano-Tera Annual Plenary Meeting.
Personalized modeling for drug concentration prediction using Support Vector Machine
You W., Widmer N., De Micheli G., 2011. pp. 1523-1527 dans BMEI 2011, 4th International Conference on Biomedical Engineering and Informatics, Proceeding of the 4th International Conference on Biomedical Engineering and Informatics. Peer-reviewed.
 
Pharmacovigilance [Pharmacovigilance update].
Livio F., Biollaz J., Buclin T., 2011. Revue Médicale Suisse, 7 (277) pp. 71-74.
 
Photodynamic therapy enhances liposomal doxorubicin distribution in tumors during isolated perfusion of rodent lungs.
Cheng C., Wang Y., Haouala A., Debefve E., Andrejevic Blant S., Krueger T., Gonzalez M., Ballini J.P., Peters S., Decosterd L. et al., 2011. European Surgical Research. Europäische Chirurgische Forschung. Recherches Chirurgicales Européennes, 47 (4) pp. 196-204.
 
Prediction of Infant Drug Exposure Through Breastfeeding: Population PK Modeling and Simulation of Fluoxetine Exposure.
Panchaud A., Garcia-Bournissen F., Csajka C., Kristensen J.H., Taddio A., Ilett K.F., Begg E.J., Ito S., 2011. Clinical Pharmacology and Therapeutics, 89 (6) pp. 830-836. Peer-reviewed.
 
Pregnancy Outcome Following Maternal Exposure To Statins: A Multicenter Prospective Study
Winterfeld U., Panchaud A., Merlob P., Rothuizen L., Cuppers-Maarschalkerweerd B., Vial T., Stephens S., Clementi M., De Santis M., Pistelli A. et al., 2011. p. 142 dans 10th Congress of the European Association for Clinical Pharmacology and Therapeutics, Basic & Clinical Pharmacology & Toxicology. Peer-reviewed.
 
Pregnancy outcome following maternal exposure to statins: a multicenter prospective study
Winterfeld U., Panchaud A., Merlob P., Rothuizen L., Cuppers-Maarschalkerweerd B., Vial T., Stephens S., Clementi M., De Santis M., Pistelli A. et al., 2011. p. 32 dans 2011 Joint Annual Meeting of the German, Swiss, and Austrian Societies for Clinical Pharmacology and Toxicology, British Journal of Clinical Pharmacology. Peer-reviewed.
 
Substance P-induced skin inflammation is not modulated by a single dose of sitagliptin in human volunteers.
Grouzmann E., Bigliardi P., Appenzeller M., Pannatier A., Buclin T., 2011. Biological Chemistry, 392 (3) pp. 217-221.
 
Successful efavirenz dose reduction guided by therapeutic drug monitoring.
Fayet Mello A., Buclin T., Decosterd L.A., Delhumeau C., di Iulio J., Fleurent A., Schneider M.P., Cavassini M., Telenti A., Hirschel B. et al., 2011. Antiviral Therapy, 16 (2) pp. 189-197.
Symposium swissYPG 2011 "Die Apotheke im Wandel"
Widmer N., Bezençon J., Locca J.F., Lüscher B., 2011. Pharmajournal, 149 (16) p. 17.
Symposium swissYPG 2011 "La Pharmacie en mutation"
Widmer N., Bezençon J., Locca J.F., Lüscher B., 2011. Pharmajournal, 149 (16) p. 19.
 
Systemic exposure to tobramycin after local antibiotic treatment with calcium sulphate as carrier material.
Wahl P., Livio F., Jacobi M., Gautier E., Buclin T., 2011. Archives of Orthopaedic and Trauma Surgery, 131 (5) pp. 657-662.
 
Tandem use of solid-phase extraction and dispersive liquid-liquid microextraction for the determination of mononitrotoluenes in aquatic environment.
Sobhi H.R., Farahani H., Kashtiaray A., Farahani M.R., 2011. Journal of Separation Science, 34 (9) pp. 1035-1040.
 
The Authors' reply to "Mistaken conclusion"
Lasserson D.S., Buclin T., Glasziou P., 2011. Heart, 97 (24) pp. 2091-2092.
 
The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans.
Hysek C.M., Simmler L.D., Ineichen M., Grouzmann E., Hoener M.C., Brenneisen R., Huwyler J., Liechti M.E., 2011. Clinical Pharmacology and Therapeutics, 90 (2) pp. 246-255.
 
Traitements de fer: preuves de l'efficacité et bonne pratique clinique [Iron therapy: proof of efficacy and good clinical practice].
Renard D., Favrat B., Livio F., Buclin T., 2011. Revue Médicale Suisse, 7 (292) pp. 923-927.
 
Who is in charge of assessing therapeutic drug monitoring? The case of imatinib.
Buclin T., Widmer N., Biollaz J., Decosterd L.A., 2011. Lancet Oncology, 12 (1) pp. 9-11. Peer-reviewed.
 
ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir.
Lubomirov R., di Iulio J., Fayet A., Colombo S., Martinez R., Marzolini C., Furrer H., Vernazza P., Calmy A., Cavassini M. et al., 2010. Pharmacogenetics and Genomics, 20 (4) pp. 217-230.
 
Angiotensin converting enzyme inhibitor induced angio-oedema: a review of the pathophysiology and risk factors.
Hoover T., Lippmann M., Grouzmann E., Marceau F., Herscu P., 2010. Clinical and Experimental Allergy, 40 (1) pp. 50-61. Peer-reviewed.
Anwendung von Galaktogoga in der Schweiz
Meyer Y., Winterfeld U., Panchaud A., 2010. Hebamme.ch = Sage-femme.ch 5 pp. 4-9. Peer-reviewed.
 
Aspergillus protein degradation pathways with different secreted protease sets at neutral and acidic pH.
Sriranganadane D., Waridel P., Salamin K., Reichard U., Grouzmann E., Neuhaus J.-M., Quadroni M., Monod M., 2010. Journal of Proteome Research, 9 (7) pp. 3511-3519.
 
Association with {beta}-COP regulates the trafficking of the newly synthesized Na,K-ATPase.
Morton M.J., Farr G.A., Hull M., Capendeguy O., Horisberger J.D., Caplan M.J., 2010. Journal of Biological Chemistry, 285 (44) pp. 33737-33746.
 
Cannabinoids time-profiles, subjective and clinical effects, simulating driving capability after smoking a joint made of neat cannabis containing 11% THC
Giroud C., Thomas A., Battistella G., Maeder P., Mall J.F., Annoni J.M., Appenzeller M., Buclin T., Staub C., Mangin P. et al., 2010. dans SOFT 2010, Annual Meeting of the Society of Forensic Toxicologists. Peer-reviewed.
 
Cardiovascular drug interactions with tyrosine kinase inhibitors
Haouala A., Widmer N., Montemurro M., Buclin T., Decosterd L., 2010. Cardiovascular Medicine, 13 (5) pp. 147-154. Peer-reviewed.
 
Comparison between a linear ion trap and a triple quadruple MS in the sensitive detection of large peptides at femtomole amounts on column.
Vatansever Bilgin, Lahrichi Sabine L., Thiocone Aly, Salluce Nunzio, Mathieu Marc, Grouzmann Eric, Rochat Bertrand, 2010. Journal of Separation Science, 33 (16) pp. 2478-2488.
 
Determination of oseltamivir and oseltamivir carboxylate in human plasma by liquid chromatography-tandem mass spectrometry
Aouri M., Zanolari B., Meylan P., Ivanyuk A., Buclin T., Decosterd L.A., Widmer N., 2010. pp. 25S dans Réunion annuelle Société Suisse de Médecine Intensive, Société Suisse d'Infectiologie, Société Suisse d'Hygiène Hospitalière, Société Suisse de Pharmacologie et Toxicologie Cliniques, Communauté Suisse d'intérêts pour soins intensifs, Invité: Société Suisse de Transplantation, Swiss Medical Forum = Forum Médical Suisse. Peer-reviewed.
 
Diagnostic accuracy of free and total metanephrines in plasma and fractionated metanephrines in urine of patients with pheochromocytoma.
Grouzmann E., Drouard-Troalen L., Baudin E., Plouin P.F., Muller B., Grand D., Buclin T., 2010. European Journal of Endocrinology / European Federation of Endocrine Societies, 162 (5) pp. 951-960.
 
Evaluation of the impact of a therapeutic drug monitoring program in a Swiss University Hospital
Fernandez S., Widmer N., Buclin T., Biollaz J., Csajka C., 2010. pp. 283-284 dans ESCP-GSASA, 38th Symposium on Clinical Pharmacy, 30 years of clinical pharmacy : a bright future ahead, Pharmacy World and Science. Peer-reviewed.
 
Feasibility of Therapeutic Drug Monitoring (TDM) for Imatinib: Preliminary considerations on the dosage adjustment approach for CML patients enrolled in the Imatinib Concentration Monitoring (I-COME) study
Gotta V., Widmer N., Decosterd L.A., Csajka C., Duchosal M.A., Chalandon Y., Heim D., Gregor M., Buclin T., 2010. pp. 90S dans 78. Jahresversammlung der Schweizerischen Gesellschaft für Innere Medizin, Swiss Medical Forum = Forum Médical Suisse. Peer-reviewed.
 
Ganciclovir exposure under a 450mg daily dosage of valganciclovir for cytomegalovirus prevention in kidney transplantation: a prospective study.
Manuel O., Pascual M., Perrottet N., Lamoth F., Venetz J.P., Decosterd L.A., Buclin T., Meylan P.R., 2010. Clinical Transplantation, 24 (6) pp. 794-800.
 
High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function.
Lamoth F., Buclin T., Pascual A., Vora S., Bolay S., Decosterd L.A., Calandra T., Marchetti O., 2010. Antimicrobial Agents and Chemotherapy, 54 (10) pp. 4360-4367.
 
Hypertension. Angio-oedème sous inhibition de l'enzyme de conversion de l'angiotensine et de la dipeptidyl-peptidase-4 [Angioedema during ACE and DPP-4 inhibition]
Waeber B., Buclin T., Grouzmann E., 2010. Revue Médicale Suisse, 6 (231) pp. 28-31.
 
Imatinib plasma concentrations variability in oncologic patients
Widmer N., 2010. 248 p., LAP Lambert Academic Publishing.
Imatinib plasma levels: correlation with clinical benefit in GIST patients.
Widmer N., Decosterd L.A., Csajka C., Montemurro M., Haouala A., Leyvraz S., Buclin T., 2010. British Journal of Cancer, 102 (7) pp. 1198-1199. Peer-reviewed.
Impact of cannabis inhalation on driving skills in occasional smokers
Thomas A., Battistella G., Maeder P., Mall J.F., Annoni J.M., Chtioui H., Appenzeller M., Buclin T., Staub C., Mangin P. et al., 2010. dans Tri-Annual Meeting of the International Council on Alcohol, Drugs and Traffic Safety.
 
Implementation of raltegravir in routine clinical practice: selection criteria for choosing this drug, virologic response rates, and characteristics of failures.
Scherrer A.U., von Wyl V., Fux C.A., Opravil M., Bucher H.C., Fayet A., Decosterd L.A., Hirschel B., Khanlari B., Yerly S. et al., 2010. Journal of Acquired Immune Deficiency Syndromes, 53 (4) pp. 464-471.
 
Is use of nifurtimox for the treatment of Chagas disease compatible with breast feeding? A population pharmacokinetics analysis.
Garcia-Bournissen F., Altcheh J., Panchaud A., Ito S., 2010. Archives of Disease In Childhood, 95 (3) pp. 224-228.
 
Mapping the impact of cannabis on driving skills in occasional smokers. 84 MT-PM cognition and attention. Executive Function
Battistella G., Maeder P., Thomas A., Mall J.F., Annoni J.M., Appenzeller M., Favrat B., Chtioui H., Buclin T., Staub C. et al., 2010. dans OHBM 2010, 16th Annual Meeting of the Organization for Human Brain Mapping.
 
Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, voriconazole-N-oxide, anidulafungin, and caspofungin.
Decosterd L.A., Rochat B., Pesse B., Mercier T., Tissot F., Widmer N., Bille J., Calandra T., Zanolari B., Marchetti O., 2010. Antimicrobial Agents and Chemotherapy, 54 (12) pp. 5303-5315. Peer-reviewed.
 
Nouvelles du swissYPG [Neuigkeiten der swissYPG]
Widmer N., Krähenbühl J.M., Grossenbacher-Flückiger C., Lüscher B., Riethmann N., Locca J.F., 2010. GSASA Journal, 24 (4) pp. 123-124.
 
Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics.
Widmer N., Meylan P., Ivanyuk A., Aouri M., Decosterd L.A., Buclin T., 2010. Clinical Pharmacokinetics, 49 (11) pp. 741-765. Peer-reviewed.
 
Pharmacokinetics and pharmacogenomics of once-daily raltegravir and atazanavir in healthy volunteers.
Neely Michael, Decosterd Laurent, Fayet Aurelie, Lee Janice Soo Fern, Margol Ashley, Kanani Meera, di Iulio Julia, von Schoen-Angerer Tido, Jelliffe Roger, Calmy Alexandra, 2010. Antimicrobial Agents and Chemotherapy, 54 (11) pp. 4619-4625.
 
Pharmacovigilance update [Pharmacovigilance update]
Livio F., Ivanyuk A., Biollaz J., Rothuizen L., Buclin T., 2010. Revue Médicale Suisse, 6 (232) pp. 128-131.
 
Photodynamic therapy selectively enhances liposomal doxorubicin uptake in sarcoma tumors to rodent lungs.
Cheng C., Debefve E., Haouala A., Andrejevic-Blant S., Krueger T., Ballini J.P., Peters S., Decosterd L., van den Bergh H., Wagnieres G. et al., 2010. Lasers in Surgery and Medicine, 42 (5) pp. 391-399.
 
Population PK-guided simulation study in children exposed to drugs in human milk
Ito S., Garcia-Bournissen F., Panchaud A., Csajka C., Kristensen J., Taddio A., Ilett K., Begg E., Tomlinson G., 2010. p. 40 dans 16th World Congress of Basic and Clinical Pharmacology, Basic and Clinical Pharmacology and Toxicology. Peer-reviewed.
 
Pregnancy outcome after maternal exposure to statins: a multicenter prospective study
Winterfeld U., Panchaud A., Merlob P., Cuppers-Maarschalkerweerd B., Vial T., Stephens S., Clementi M., De Santis M., Pistelli A., Berlin M. et al., 2010. dans 21st Annual Meeting of the European Network Teratogen Information Services (ENTIS).
Prospective assessment of CYP2D6 by genotyping, phenotyping and measurement of tamoxifen, PD 05-09 4-hydroxy-tamoxifen and endoxifen in breast cancer patients treated with tamoxifen.
Zaman K., Dahmane E., Perey L., Buclin T., Berthod G., Bodmer A., Galmiche M., Leyvraz S., Eap C., Csajka C. et al., 2010. dans 33rd Annual San Antonio Breast Cancer Symposium.
Prospective monitoring of cefepime in intensive care unit adult patients.
Chapuis T.M., Giannoni E., Majcherczyk P.A., Chioléro R., Schaller M.D., Berger M.M., Bolay S., Décosterd L.A., Bugnon D., Moreillon P., 2010. Critical Care, 14 (2) pp. R51.
 
Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadir.
Gutmann C., Cusini A., Günthard H.F., Fux C., Hirschel B., Decosterd L.A., Cavassini M., Yerly S., Vernazza P.L., Swiss HIV Cohort Study (SHCS), 2010. Aids, 24 (15) pp. 2347-2354.
 
Rapid occurrence of depression following addition of sodium oxybate to modafinil.
Rossetti A.O., Heinzer R.C., Tafti M., Buclin T., 2010. Sleep Medicine, 11 (5) pp. 500-501. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Fax. +41 21 692 26 15
Swiss University